Your Location:
Home >
Browse articles >
Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate
LETTER TO THE EDITOR | Updated:2023-03-20
    • Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate

    • Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate

    • 解放军医学杂志(英文版)   2022年9卷第6期 页码:754-756
    • DOI:10.1186/s40779-021-00364-x    

      中图分类号:
    • 纸质出版:2022-12

    Scan QR Code

  • Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate[J]. 解放军医学杂志(英文版), 2022,9(6):754-756. DOI: 10.1186/s40779-021-00364-x.

    Wang JY, Yu GP, Li L, Lin GW, Ye DW. Early prostate specific antigen decline and its velocity are independent predictive factors for outcomes of mCRPC patients treated with abiraterone acetate. Mil Med Res. 2022;9(1):5. DOI: 10.1186/s40779-021-00364-x.

  •  
  •  
icon
The trial reading is over, you can activate your VIP account to continue reading.
Deactivate >
icon
The trial reading is over. You can log in to your account, go to the personal center, purchase VIP membership, and read the full text.
Already a VIP member?
Log in >

0

浏览量

1

Downloads

0

CSCD

文章被引用时,请邮件提醒。
Submit
工具集
下载
参考文献导出
分享
收藏
添加至我的专辑

相关文章

Standardizing the classification of gastric cancer patients with limited and adequate number of retrieved lymph nodes: an externally validated approach using real-world data
钢拱桥极限承载力的综合三因素检算方法
长大货物列车空气管系3维充气模型的数值仿真
地铁高架槽形梁足尺模型破坏试验与空间分析研究
二取二制式计算机联锁系统中的通信技术

相关作者

Wei Wang
Yu-Jie Yang
Ri-Hong Zhang
Jing-Yu Deng
Zhe Sun
Sharvesh Raj Seeruttun
Zhen-Ning Wang
Hui-Mian Xu

相关机构

Department of Gastric Surgery, Sun Yat-sen University Cancer Center
State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
Department of Gastric Cancer Surgery, Tianjin Medical University Cancer Institute and Hospital
Department of Surgical Oncology, the First Hospital of China Medical University
0